---
created: 2025-04-13
updated: 2025-04-13T10:51
id: OW^v9C$sQ[
specialty: neuro
specialty_id: 220
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::17-psych::04-pharm::03-antipsychotics
  - source/ak-step1-v11::
  - theme/firstaid::13-psychiatry::03-pharm::05-atypical-antipsychotics
  - source/ak-step1-v11::
  - source/ome-banner::clinical::12-psychiatry
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::13-psychiatric::03-extrapyramidal-symptoms-(including-acute-dystonia)
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::13-psychiatric::16-atypical-antipsychotics
  - source/ak-step1-v11::
  - theme/pixorize::03-pharm::16-psych::atypical-antipsychotics
  - source/ak-step1-v11::
  - theme/sketchypharm::06-neuro/psych::05-antipsychotics-&-parkinsons::02-second-generation-antipsychotics
  - source/ak-step1-v11::
  - theme/uworld::10000-99999::15000-15999::15416
  - source/ak-step1-v11::$ankingupdates::$errata::v11
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary
  - source/ak-step1-v11::^systems::neuro::pharmacology
  - source/ak-step2-v11::!shelf::fm
  - source/ak-step2-v11::!shelf::fm::no-dupes
  - source/ak-step2-v11::!shelf::psych
  - source/ak-step2-v11::!shelf::psych::no-dupes
  - source/ak-step2-v11::
  - theme/b&b::03-psych::04-psychopharmacology::02-antipsychotics::03-atypical-antipsychotics
  - source/ak-step2-v11::
  - theme/ome::12-psychiatry::15-pharm-2
  - source/ak-step2-v11::
  - source/ome-banner
  - source/ak-step2-v11::
  - theme/resources-by-rotation::fm::ome::psych::pharm
  - source/ak-step2-v11::
  - theme/resources-by-rotation::psych::fapsych::pharm
  - source/ak-step2-v11::
  - theme/resources-by-rotation::psych::uworld::dorian
  - source/ak-step2-v11::
  - theme/subjects::psychiatry::07-psychotic-disorders::*antipsychotics::atypical-antipsychotics::*basics
  - source/ak-step2-v11::
  - theme/uworld::10000-99999::11000-11999::11958
  - source/ak-step2-v11::original-decks::dorian::fam::ome::psych::pharm
  - source/ak-step2-v11::original-decks::dorian::psych::fapsych::pharm
  - source/ak-step2-v11::original-decks::dorian::psych::uw"
type: flashcard
---

# Question
Compared to typical antipsychotics, atypical aka 2nd gen antipsychotics are **less::more/less** likely to cause extrapyramidal symptoms (EPS)

---

# Answer
note: extrapyramidal symptoms (e.g. dystonia, akathisia) are still possible